On 11 December, The Coca-Cola Company (NYSE:KO) shares fell -1.15% and was closed at $42.27. KO EPS growth in last 5 year was 1.70%. The Coca-Cola Company (NYSE:KO) year to date (YTD) performance is 3.45%.
The Coca-Cola Company (NYSE:KO) announced the signing of letters of intent with three U.S. bottlers — Coca-Cola Beverages Florida, Viking Coca-Cola Bottling Company and Coca-Cola Bottling Company United (“United”) — to grant expanded distribution territories in five U.S. states. The deals are subject to the companies reaching a definitive agreement.
Comcast Corporation (NASDAQ:CMCSA) shares fell -2.85% in last trading session and ended the day at $57.97. CMCSA Gross Margin is 69.80% and its has a return on assets of 5.10%. Comcast Corporation (NASDAQ:CMCSA) quarterly performance is 3.50%.
Comcast Corporation (NASDAQ:CMCSA) opened an Xfinity retail store in Batavia, according to a news release. The Xfinity store is at 57 and 59 S. Randall Road in The Shoppes at Windmill Place Shopping Center in Batavia, according to a news release.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) caters to the Healthcare space. Its weekly performance is -17.31%. On the last day of trading company shares ended up at $4.30. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) distance from 50-day simple moving average (SMA50) is -1.54%.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced that John P. Butler has been appointed as a new independent director to its board of directors pursuant to the company’s financing transaction with The Baupost Group, L.L.C., effective immediately. Mr. Butler is an industry veteran with significant experience in guiding corporate strategy.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares fell -0.11% in last trading session and ended the day at $64.49. TEVA Gross Margin is 57.20% and its has a return on assets of 3.70%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) quarterly performance is 2.15%.
On 8 December, Teva Pharmaceutical Industries Limited (NYSE:TEVA) and Eagle Pharmaceuticals, Inc. announce that the U.S. Food and Drug Administration (FDA) has approved BENDEKA™, (bendamustine hydrochloride) injection, a liquid, low-volume (50 mL) and short-time 10-minute infusion formulation of bendamustine. BENDEKA is approved for the treatment of patients with chronic lymphocytic leukemia (CLL) and for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
Corindus Vascular Robotics Inc. (NYSEMKT:CVRS) caters to the Healthcare space. Its weekly performance is 0.99%. On the last day of trading company shares ended up at $3.07. Corindus Vascular Robotics Inc. (NYSEMKT:CVRS) distance from 50-day simple moving average (SMA50) is -1.91%.
Corindus Vascular Robotics Inc. (NYSEMKT:CVRS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, Market Beat.com reports.
Leave a Reply